CDH2 and diabetic kidney disease: In this study, we aim to analyze circulatory concentrations of N-cadherin in diabetic nephropathy patients and compare it to the levels in non-diabetic and diabetic controls to determine whether N-cadherin can serve as a biomarker for diabetic nephropathy diagnosis.